DENTSPLY SIRONA XRAY Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Connected Technology Solutions | $246M-17.7% | $299M+15.4% | $259M+6.6% | $243M+3.4% | $235M-19.8% | |
| Essential Dental Solutions | $350M-5.9% | $372M+4.2% | $357M-7.8% | $387M+9.6% | $353M+2.0% | |
| Orthodontic and Implant Solutions | $199M-1.5% | $202M-1.5% | $205M-9.3% | $226M+4.1% | $217M+17.3% | |
| Wellspect Healthcare | $85M-3.4% | $88M+6.0% | $83M+3.8% | $80M+8.1% | $74M-8.6% | |
| Operating Income (Loss) by Business | ||||||
| Connected Technology Solutions | -$6M-126% | $23M+130% | $10M-16.7% | $12M+71.4% | $7M-85.7% | |
| Essential Dental Solutions | $121M+9.0% | $111M-4.3% | $116M-23.2% | $151M+11.9% | $135M+26.2% | |
| Orthodontic and Implant Solutions | $8M+100% | $4M-81.8% | $22M-51.1% | $45M+21.6% | $37M— | |
| Wellspect Healthcare | $23M-4.2% | $24M-14.3% | $28M+12.0% | $25M-3.8% | $26M+4.0% | |
| Adjusted cost of products sold by Business | ||||||
| Connected Technology Solutions | $156M-14.3% | $182M+15.9% | $157M+12.1% | $140M+3.7% | $135M-10.0% | |
| Essential Dental Solutions | $132M-13.7% | $153M+9.3% | $140M+1.4% | $138M+11.3% | $124M-12.1% | |
| Orthodontic and Implant Solutions | $104M-1.9% | $106M+11.6% | $95M-3.1% | $98M+5.4% | $93M-7.0% | |
| Wellspect Healthcare | $37M-2.6% | $38M+15.2% | $33M0.0% | $33M+22.2% | $27M-20.6% | |
| Payments for Restructuring by Business | ||||||
| Connected Technology Solutions | $2M+100% | $1M— | $0-100% | $2M-71.4% | $7M+40.0% | |
| Essential Dental Solutions | $3M— | $0-100% | $3M0.0% | $3M0.0% | $3M-78.6% | |
| Orthodontic and Implant Solutions | $4M0.0% | $4M0.0% | $4M+100% | $2M0.0% | $2M-33.3% | |
| Wellspect Healthcare | $0— | —— | —— | $1M0.0% | $1M0.0% | |
| Translation by Business | ||||||
| Connected Technology Solutions | $0— | —— | —— | $0— | $0— | |
| Essential Dental Solutions | -$3M-250% | $2M— | $0-100% | $21M+110% | $10M+177% | |
| Orthodontic and Implant Solutions | $0— | —— | —— | $10M-47.4% | $19M+145% | |
| Wellspect Healthcare | -$3M— | —— | —— | $21M+250% | $6M+138% | |
| Adjusted general and administrative (“G&A”) expenses by Business | ||||||
| Connected Technology Solutions | $23M0.0% | $23M+15.0% | $20M0.0% | $20M+5.3% | $19M+11.8% | |
| Essential Dental Solutions | $20M-4.8% | $21M+16.7% | $18M-10.0% | $20M+11.1% | $18M0.0% | |
| Orthodontic and Implant Solutions | $21M0.0% | $21M+5.0% | $20M+17.6% | $17M-22.7% | $22M-40.5% | |
| Wellspect Healthcare | $8M+14.3% | $7M0.0% | $7M0.0% | $7M+16.7% | $6M0.0% | |
| Total Depreciation and Amortization by Business | ||||||
| Connected Technology Solutions | $37M-24.5% | $49M+2.1% | $48M+4.3% | $46M+7.0% | $43M-4.4% | |
| Essential Dental Solutions | $8M0.0% | $8M-11.1% | $9M+12.5% | $8M-11.1% | $9M0.0% | |
| Orthodontic and Implant Solutions | $23M-4.2% | $24M0.0% | $24M+4.3% | $23M+21.1% | $19M-17.4% | |
| Wellspect Healthcare | $5M0.0% | $5M0.0% | $5M0.0% | $5M+150% | $2M-60.0% | |
| Restructuring Reserve, Accrual Adjustment by Business | ||||||
| Connected Technology Solutions | $0+100% | -$2M— | $0+100% | -$1M0.0% | -$1M— | |
| Essential Dental Solutions | $0— | $0+100% | -$1M— | $0— | $0+100% | |
| Orthodontic and Implant Solutions | $0+100% | -$1M— | $0— | $0— | $0-100% | |
| Wellspect Healthcare | $0— | $0— | $0— | $0— | $0+100% | |
| Adjusted selling expenses by Business | ||||||
| Connected Technology Solutions | $53M-1.9% | $54M-1.8% | $55M+1.9% | $54M-5.3% | $57M-3.4% | |
| Essential Dental Solutions | $69M-14.8% | $81M+5.2% | $77M+6.9% | $72M+1.4% | $71M-4.1% | |
| Orthodontic and Implant Solutions | $54M-6.9% | $58M+3.6% | $56M+3.7% | $54M0.0% | $54M-14.3% | |
| Wellspect Healthcare | $14M-12.5% | $16M+23.1% | $13M0.0% | $13M0.0% | $13M0.0% | |
| Restructuring Reserve by Business | ||||||
| Connected Technology Solutions | $22M+2,100% | $1M-50.0% | $2M+100% | $1M-66.7% | $3M-66.7% | |
| Essential Dental Solutions | $18M+350% | $4M+100% | $2M-60.0% | $5M-16.7% | $6M-45.5% | |
| Orthodontic and Implant Solutions | $20M+567% | $3M-50.0% | $6M-14.3% | $7M-12.5% | $8M-11.1% | |
| Wellspect Healthcare | $3M+50.0% | $2M0.0% | $2M0.0% | $2M-33.3% | $3M0.0% | |
| Adjusted research and development (“R&D”) expenses by Business | ||||||
| Connected Technology Solutions | $20M+17.6% | $17M0.0% | $17M0.0% | $17M0.0% | $17M-5.6% | |
| Essential Dental Solutions | $8M+33.3% | $6M0.0% | $6M0.0% | $6M+20.0% | $5M-16.7% | |
| Orthodontic and Implant Solutions | $12M-7.7% | $13M+8.3% | $12M0.0% | $12M+9.1% | $11M-15.4% | |
| Wellspect Healthcare | $3M0.0% | $3M+50.0% | $2M0.0% | $2M0.0% | $2M-33.3% | |
| Goodwill, Impaired, Accumulated Impairment Loss by Business | ||||||
| Connected Technology Solutions | $291M0.0% | $291M0.0% | $291M0.0% | $291M0.0% | $291M0.0% | |
| Essential Dental Solutions | $0— | $0— | $0— | $0— | $0— | |
| Orthodontic and Implant Solutions | $1.3B0.0% | $1.3B+9.8% | $1.18B+27.2% | $929M+20.2% | $773M0.0% | |
| Wellspect Healthcare | $0— | $0— | $0— | $0— | $0— | |
| Goodwill by Business | ||||||
| Connected Technology Solutions | $0— | $0— | $0— | $0— | $0— | |
| Essential Dental Solutions | $857M-0.3% | $860M+0.2% | $858M-0.2% | $860M+2.5% | $839M+1.2% | |
| Orthodontic and Implant Solutions | $0— | $0-100% | $123M-67.3% | $376M-28.0% | $522M+3.8% | |
| Wellspect Healthcare | $285M-1.0% | $288M-0.3% | $289M-1.0% | $292M+7.7% | $271M+2.3% | |
| Provisions by Business | ||||||
| Connected Technology Solutions | $23M+1,050% | $2M+100% | $1M0.0% | $1M-50.0% | $2M-50.0% | |
| Essential Dental Solutions | $17M+750% | $2M+100% | $1M-50.0% | $2M+200% | -$2M-150% | |
| Orthodontic and Implant Solutions | $21M+950% | $2M-33.3% | $3M+200% | $1M0.0% | $1M— | |
| Wellspect Healthcare | $1M— | —— | —— | —— | $1M0.0% | |
| Goodwill, Impairment Loss by Business | ||||||
| Connected Technology Solutions | $0— | $0— | $0— | $0— | $0— | |
| Essential Dental Solutions | $0— | $0— | $0— | $0— | $0— | |
| Orthodontic and Implant Solutions | $0-100% | $116M-54.2% | $253M+62.2% | $156M— | $0-100% | |
| Wellspect Healthcare | $0— | $0— | $0— | $0— | $0— | |
| Net Sales by Product | ||||||
| CAD/CAM | $111M-20.1% | $139M+25.2% | $111M+3.7% | $107M+5.9% | $101M-28.9% | |
| Equipment & Instruments | $135M-15.6% | $160M+8.1% | $148M+8.8% | $136M+1.5% | $134M-11.3% | |
| Implants & Prosthetics | $154M+2.7% | $150M-1.3% | $152M-6.7% | $163M+3.2% | $158M-2.5% | |
| Orthodontics | $45M-13.5% | $52M-1.9% | $53M-15.9% | $63M+6.8% | $59M+157% | |
| Net Sales by Geography | ||||||
| Americas | $330M— | —— | —— | —— | $364M— | |
| APAC | $115M— | —— | —— | —— | $108M— | |
| EMEA | $435M— | —— | —— | —— | $407M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does DENTSPLY SIRONA break its business down?
- DENTSPLY SIRONA (XRAY) reports net sales by business across 4 parts — Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions and Wellspect Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does DENTSPLY SIRONA's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in DENTSPLY SIRONA's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.